非嗜酸性粒细胞性哮喘与固有免疫反应
Non-eosinophilic asthma and the innate immune response.
作者信息
Pavord Ian D
出版信息
Thorax. 2007 Mar;62(3):193-4. doi: 10.1136/thx.2006.065805.
Abstract
Pathological heterogeneity of asthma
摘要
哮喘的病理异质性
相似文献
1
Non-eosinophilic asthma and the innate immune response.非嗜酸性粒细胞性哮喘与固有免疫反应
Thorax. 2007 Mar;62(3):193-4. doi: 10.1136/thx.2006.065805.
2
Innate immunity in asthma.哮喘中的固有免疫
Paediatr Respir Rev. 2008 Dec;9(4):263-70. doi: 10.1016/j.prrv.2008.05.007. Epub 2008 Oct 15.
3
[Role of eosinophils in asthma].[嗜酸性粒细胞在哮喘中的作用]
Rev Mal Respir. 2000 Feb;17(1 Pt 2):195-201.
4
T cells and eosinophils in asthma.哮喘中的T细胞和嗜酸性粒细胞。
Acta Microbiol Immunol Hung. 1998;45(1):19-29.
5
Immunological aspects of extrinsic and intrinsic asthma.外源性和内源性哮喘的免疫学方面
Agents Actions Suppl. 1989;28:233-8.
6
Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.功能性CD137受体在IgE介导的过敏反应患者的嗜酸性粒细胞中表达，但在非IgE介导的嗜酸性粒细胞疾病患者的嗜酸性粒细胞中不表达。
J Allergy Clin Immunol. 2001 Jul;108(1):21-8. doi: 10.1067/mai.2001.116864.
7
Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.白细胞介素-18诱导的固有T细胞活化对伴有黏液高分泌和气道高反应性的气道炎症的作用。
Int Immunol. 2006 Jun;18(6):847-55. doi: 10.1093/intimm/dxl021. Epub 2006 Apr 12.
8
A new look at type I immediate hypersensitivity immune reactions.对I型速发型超敏免疫反应的新认识。
Ann Allergy. 1976 May;36(5):337-41.
9
[Role of eosinophilia in atopic pathology].[嗜酸性粒细胞增多在特应性病理学中的作用]
Med Trop (Mars). 1998;58(4 Suppl):444-6.
10
Immunological alterations in asthma: cell mediated immune responses.哮喘中的免疫改变：细胞介导的免疫反应。
J Assoc Physicians India. 1979 Feb;27(2):77-82.
引用本文的文献
1
Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System.基于美国食品药品监督管理局不良事件报告系统的瑞利珠单抗不成比例性分析。
Ther Adv Drug Saf. 2024 Oct 7;15:20420986241284112. doi: 10.1177/20420986241284112. eCollection 2024.
2
Upregulation of microRNA‑16 alters the response to inhaled β‑agonists in patients with asthma though modulating expression of ADRB2.miR-16 的上调通过调节 ADRB2 的表达改变了哮喘患者对吸入β激动剂的反应。
Mol Med Rep. 2019 May;19(5):4027-4034. doi: 10.3892/mmr.2019.10097. Epub 2019 Mar 28.
3
Distinguishing adult-onset asthma from COPD: a review and a new approach.区分成人起病型哮喘与慢性阻塞性肺疾病：综述与新方法
Int J Chron Obstruct Pulmon Dis. 2014 Sep 9;9:945-62. doi: 10.2147/COPD.S46761. eCollection 2014.
4
Trithorax complex component Menin controls differentiation and maintenance of T helper 17 cells.三体胸复合体成分Menin控制辅助性T细胞17的分化和维持。
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12829-34. doi: 10.1073/pnas.1321245111. Epub 2014 Aug 18.
5
Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational study.吸入性糖皮质激素与长效β₂受体激动剂固定复方制剂报销政策变化对阻塞性肺疾病的影响：一项基于人群的观察性研究。
Int J Clin Pract. 2014 Jul;68(7):812-9. doi: 10.1111/ijcp.12473.
6
Heterogeneity of glucocorticoid resistance in patients with bronchial asthma.支气管哮喘患者糖皮质激素抵抗的异质性
Int J Biomed Sci. 2010 Sep;6(3):158-66.
7
Clinical characteristics and long-term outcomes related to sputum eosinophilia in Korean asthmatics.韩国哮喘患者痰液嗜酸性粒细胞增多相关的临床特征及长期预后
Asia Pac Allergy. 2011 Apr;1(1):16-24. doi: 10.5415/apallergy.2011.1.1.16. Epub 2011 Mar 30.
8
A modeling-derived hypothesis on chronicity in respiratory diseases: desensitized pathogen recognition secondary to hyperactive IRAK/TRAF6 signaling.一项基于模型得出的关于呼吸系统疾病慢性化的假说：继发于 IRAK/TRAF6 信号过度激活的病原体识别脱敏。
PLoS One. 2009;4(4):e5332. doi: 10.1371/journal.pone.0005332. Epub 2009 Apr 24.
9
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice.辅助性T细胞17（TH17）介导小鼠体内对类固醇耐药的气道炎症和气道高反应性。
J Immunol. 2008 Sep 15;181(6):4089-97. doi: 10.4049/jimmunol.181.6.4089.
本文引用的文献
1
Innate immune activation in neutrophilic asthma and bronchiectasis.嗜中性粒细胞性哮喘和支气管扩张症中的先天性免疫激活
Thorax. 2007 Mar;62(3):211-8. doi: 10.1136/thx.2006.061358. Epub 2006 Jul 14.
2
Multiple inflammatory hits and the pathogenesis of severe airway disease.多重炎症打击与重症气道疾病的发病机制
Eur Respir J. 2006 May;27(5):884-8. doi: 10.1183/09031936.06.00128105.
3
Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.戒烟对哮喘吸烟者肺功能和气道炎症的影响。
Am J Respir Crit Care Med. 2006 Jul 15;174(2):127-33. doi: 10.1164/rccm.200510-1589OC. Epub 2006 Apr 27.
4
The effect of telithromycin in acute exacerbations of asthma.泰利霉素在哮喘急性加重期的作用。
N Engl J Med. 2006 Apr 13;354(15):1589-600. doi: 10.1056/NEJMoa044080.
5
Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients.痰液嗜酸性粒细胞水平低预示有症状的哮喘患者对倍氯米松治疗无反应。
Chest. 2006 Mar;129(3):565-72. doi: 10.1378/chest.129.3.565.
6
Evidence of a role of tumor necrosis factor alpha in refractory asthma.肿瘤坏死因子α在难治性哮喘中作用的证据。
N Engl J Med. 2006 Feb 16;354(7):697-708. doi: 10.1056/NEJMoa050580.
7
Airway function and markers of airway inflammation in patients with treated hypothyroidism.接受治疗的甲状腺功能减退症患者的气道功能和气道炎症标志物。
Thorax. 2005 Mar;60(3):249-53. doi: 10.1136/thx.2004.034900.
8
The influence of smoking on the treatment response in patients with asthma.吸烟对哮喘患者治疗反应的影响。
Curr Opin Allergy Clin Immunol. 2005 Feb;5(1):57-63. doi: 10.1097/00130832-200502000-00011.
9
Asthma and cigarette smoking.哮喘与吸烟。
Eur Respir J. 2004 Nov;24(5):822-33. doi: 10.1183/09031936.04.00039004.
10
Location, location, location: microlocalisation of inflammatory cells and airway dysfunction.位置，位置，还是位置：炎症细胞的微定位与气道功能障碍
Thorax. 2004 Sep;59(9):734-5. doi: 10.1136/thx.2004.026328.
Zotero 插件